Semi-synthetic mithramycin derivatives with anti-cancer activity
US-9447135-B2 · Sep 20, 2016 · US
US2016153018A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016153018-A1 |
| Application number | US-201615000774-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 19, 2016 |
| Priority date | Oct 3, 2014 |
| Publication date | Jun 2, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebausoside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside (Reb W).
Opening claim text (preview).
1 .- 7 . (canceled) 8 . A method for synthesizing rebaudioside E from rubusoside, the method comprising: preparing a reaction mixture comprising rubusoside, substrates selected from the group consisting of sucrose, uridine diphosphate (UDP) and uridine diphosphate-glucose (UDP-glucose), and a UDP-glycosyltransferase selected from the group consisting of HV1, EUGT11 and a UDP-glycosyltransferase fusion enzyme (EUS); and optionally, a sucrose synthase; and incubating the reaction mixture for a sufficient time to produce rebaudioside E, wherein a glucose is covalently coupled to rubusoside to produce rebaudioside KA or stcviosidc, and a glucose is covalently coupled to rebaudioside KA to produce rebaudioside E. 9 . The method of claim 8 further comprising adding a sucrose synthase to the reaction mixture. 10 . The method of claim 9 , wherein the sucrose synthase is selected from the group consisting of an Arabidopsis sucrose synthase 1; an Arabidopsis sucrose synthase 3; and a Vigna radiate sucrose synthase. 11 . The method of claim 10 , wherein the sucrose synthase is an Arabidopsis thaliana sucrose synthase 1. 12 . The method of claim 8 , wherein the UDP-glycosyltransferase fusion enzyme is selected from the group consisting of an EUGT11 uridine diphospho glycosyltransferase domain coupled to a sucrose synthase domain. 13 . The method of claim 12 , wherein the sucrose synthase domain is selected from the group consisting of an Arabidopsis sucrose synthase 1; an Arabidopsis sucrose synthase 3; and a Vigna radiate sucrose synthase. 14 . The method of claim 13 , wherein the sucrose synthase domain is an Arabidopsis thaliana sucrose synthase 1. 15 .- 28 . (canceled)
Hexosyltransferases (2.4.1) · CPC title
Terpene glycosides · CPC title
Sucrose synthase (2.4.1.13) · CPC title
produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins · CPC title
Sweeteners · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.